Cover Image
Market Research Report

Global Sleep Aids Market - 2019-2026

Published by DataM Intelligence Product code 834585
Published Content info 130-180 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Sleep Aids Market - 2019-2026
Published: May 1, 2019 Content info: 130-180 Pages
Description

Global Sleep Aids Market Overview

The global sleep aids market was worth the US $XX billion in 2018 and is expected to reach US $XX billion by 2026, at a CAGR of XX% during the forecast period.

Sleep aids are pills medical devices used to treat and diagnose various sleep disturbances and disorders, such as sleep apnea and insomnia. Products such as specialized mattresses and pillows which can induce sleep are also categorized as sleeping aids. Sleep aid medications are commonly referred to as hypnotics or sleeping pills. Hypnotics are a class of psychoactive drugs whose primary function is to induce sleep and to treat insomnia (sleeplessness). These sleep disorders are expected to adversely affect human health and lead to several chronic diseases, such as high blood pressure, diabetes. Thus, it is essential to treat and diagnose these disorders at an early stage. Growing

Global Sleep Aids Market - Market Dynamics

Increasing prevalence of insomnia and obstructive sleep apnea (OSA) disorders, rising use of portable sleep apnea devices, improving healthcare facilities, the surge in demand for sleeping pills attributed to stressful modern lifestyle, and increasing geriatric population are the key factors driving the growth of the market. According to Centres for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have sleeping issues. Increasing awareness about sleep disorders and technological advancements are boosting the global sleep aids market.

Growing awareness initiatives by various organizations to educate people and medical practitioners about healthy sleep habits are propelling the global sleep aids market. For instance, in March 2018, the National Sleep Foundation conducted the sleep awareness week with the theme 'Begin with Sleep Moreover'.

However, the adverse effects of using sleeping aids are hampering the global sleep aids market. In older adults, using these pills can cause memory problems and drug addiction issues.

Global Sleep Aids Market - Segment Analysis

Based on product the global Sleep Aids market is broadly segmented as mattress and pillows, medication, sleep apnea devices, and others. Among all these mattresses and pillows accounted for major market share in 2018, and it is projected to grow at a significant pace over the forecast period (2019-2026). This is attributed to the fact that mattresses and pillows are a cost-effective solution, due to which these are widely adopted among the global population. Additionally, technical advancements and developments by manufacturers are driving the mattresses and pillows segment. In May 2017, DeVilbiss Healthcare introduced the P903 Full Electric Expandable Width Low Height Long-Term Care (LTC) bed, to its premium line of mattresses and bedding products.

Sleeping aid drugs include prescription drugs such as benzodiazepine, antidepressants, orexin antagonists, and over the counter (OTC) drugs such as antihistamines, melatonin, and others. Among these, uptake of OTC drugs is growing at a significant rate, owing to low cost and no adverse effects compared to others. Sleep aid devices include positive airway pressure (PAP) machines and oral appliances. Oral appliance therapy is an effective, non-invasive treatment. It is more comfortable, easy to wear, and portable.

Based on the sleep disorder Sleep Deprivation, Narcolepsy, insomnia, sleep apnea, and others. Among all these insomnia accounted for major market share in 2018. It is due to the rise in the prevalence of the number of insomnia cases over the years. Over the forecast period (2019-2026) sleep apnea disorder is growing at a high pace. The growing prevalence of OSA (Obstructive Sleep Apnea), along with technological advancements are anticipated to boost the sleep apnea segment. According to WHO (World Health Organization), in 2018, the prevalence of sleep apnea impacts more than 936 million people worldwide which is nearly ten times greater than the 2007 estimation. Thus, the growing incidence of OSA is expected to drive the global sleep aids market.

Global Sleep Aids Market - Geographical Analysis

The global Sleep Aids market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America accounted for a major share in the global sleeping aids market in 2018. This is attributed to the rising number of sleep apnea disorders. The Asia Pacific is expected to be the fastest growing region in the global sleeping aids market, owing to the increasing demand for sleeping pills due to stressful modern lifestyle. With the ever-increasing geriatric population, the frequency of sleep disorders is rising, which further creates demand for these products. According to the Food and Drug Administration (FDA), in 2014, in Japan sold around 339 million sleeping pills.

Global Sleep Aids Market - Competitive Analysis

Significant players of the global sleep aids market are Teva Pharmaceutical Industries Ltd., Merck & Co., Sanofi, DeVilbiss Healthcare LLC. (Drive Medical), Pfizer Inc., SleepMed Inc., Cadwell Laboratories Inc., Compumedics Limited, Natus Medical Incorporated, GlaxoSmithKline plc., and others. The product launches, collaboration, and product agreements, and other key developments are the dominating strategies adopted by the market players to enhance their product portfolio in the global sleep aids market.

  • In April 2019, UCHealth incorporated new sleep apnea advance device, remede implantable device, to treat central sleep apnea.
  • In March 2019, the FDA approved Jazz Pharmaceuticals' Sunosi (solriamfetol) drug to treat obstructive sleep apnea (OSA).
  • In January 2015, DeVilbiss Healthcare added the new Quest™ Full Face CPAP Mask to its growing line of CPAP therapy interfaces.

Why Purchase the Report?

  • Visualize the composition of the Sleep Aids market across each indication, in terms of Product and disorder options, highlighting the key commercial assets and players.
  • Identify commercial opportunities in Sleep Aids market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Sleep Aids market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key products of all major market players

Target Audience:

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
Table of Contents

Table of Contents

1. Global Sleep Aids Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Sleep Aids Market - Market Definition and Overview

3. Global Sleep Aids Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Disorder Type
  • 3.3. Market Snippet by Region

4. Global Sleep Aids Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Awareness programs by Various Organizations
      • 4.1.1.2. Increasing sleeping disorders
    • 4.1.2. Restraints
      • 4.1.2.1. Adverse effects of using sleeping aids
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Sleep Aids Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis

6. Global Sleep Aids Market - By Product

    • 6.1.1. Introduction
    • 6.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 6.1.3. Market Attractiveness Index, By Product
  • 6.2. Sleep apnea devices
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
      • 6.2.2.1. Positive airway pressure (PAP) devices
      • 6.2.2.2. Facial interfaces devices
      • 6.2.2.3. Oral devices
      • 6.2.2.4. Adaptive servo-ventilation(ASV)
      • 6.2.2.5. Others
  • 6.3. Medication
    • 6.3.1. Prescription drugs
    • 6.3.2. Over-the-counter (OTC) drugs
    • 6.3.3. Herbal remedies
  • 6.4. Mattresses and pillows
  • 6.5. Others

7. Global Sleep Aids Market - By Disorder Type

    • 7.1.1. Introduction
    • 7.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disorder Type
    • 7.1.3. Market Attractiveness Index, By Disorder Type
  • 7.2. Insomnia
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
  • 7.3. Sleep Deprivation
  • 7.4. Narcolepsy
  • 7.5. Sleep Apnea
  • 7.6. Others

8. Global Sleep Aids Market - By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disorder Type
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disorder Type
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. The U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disorder Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disorder Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. Middle East & Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disorder Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

9. Global Sleep Aids Market - Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Competitor Sleep Aids Strategy Analysis
  • 9.3. Comparative Product Portfolio Analysis
  • 9.4. Market Positioning/Share Analysis
  • 9.5. Mergers and Acquisitions Analysis

10. Global Sleep Aids Market - Company Profiles

  • 10.1. Teva Pharmaceutical Industries Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Merck & Co.
  • 10.3. Sanofi
  • 10.4. DeVilbiss Healthcare LLC.
  • 10.5. Pfizer Inc.
  • 10.6. SleepMed Inc.
  • 10.7. Cadwell Laboratories Inc.
  • 10.8. Compumedics Limited
  • 10.9. Natus Medical Incorporated
  • 10.10. GlaxoSmithKline Plc

11. Global Sleep Aids Market - Premium Insights

12. Global Sleep Aids Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us
Back to Top